What is the dose of glucagon for peptide product composition?
Published: July 22, 2026 14:46
Author: Robert Cannon
Abstract: Glucagon dosing for peptide products varies by formulation (1 mg standard; 0.5-2 mg for GLP-1 combinations). Market trends show 12.3% CAGR growth driven by diabetes/obesity applications. Leading brands (Novo Nordisk, Eli Lilly) dominate via superior stability and purity (>99%). Key technical advantages include rapid onset; disadvantages involve short half-life. Product composition requires strict GMP certification (FDA/EMA). Selection criteria prioritize potency, cold-chain logistics, and regulatory compliance.